Skip to main content
Premium Trial:

Request an Annual Quote

PierianDx Licenses Washington University Technology

NEW YORK (GenomeWeb) – Genomic data firm PierianDx today announced it is exclusively licensing a proprietary genetic testing tool and processes from Washington University in St. Louis.

PierianDx will offer the tool, called the Clinical Genomicist Workstation, to other clinical labs "giving them an end-to-end solution for managing clinical next-generation sequencing processes." CGW is a software platform for NGS clinical tests that manages data and workflow, the St. Louis-based company said on its website.

Along with the CGW software, PierianDx offers an IT backbone, integrated processes, access to a bioinformatics database, and consulting services. Washington University will continue to have access to PierianDx's technology for use in its clinical practice and research.

Financial and other terms of the deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.